Chemistry:Clovoxamine

From HandWiki
Short description: Chemical compound
Clovoxamine
Clovoxamine Structure.svg
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H21ClN2O2
Molar mass284.78 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Clovoxamine (INN) (developmental code name DU-23811) is a drug that was discovered in the 1970s and was subsequently investigated as an antidepressant and anxiolytic agent but was never marketed.[1][2][3] It acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), with little affinity for the muscarinic acetylcholine, histamine, adrenergic, and serotonin receptors.[4][5] The compound is structurally related to fluvoxamine.

References

  1. "Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine". Advances in Biochemical Psychopharmacology 32: 69–75. 1982. PMID 7046368. 
  2. "Anxiety neurosis in general practice. A double-blind comparative study of diazepam and clovoxamine, a novel inhibitor of noradrenaline and serotonin reuptake". International Clinical Psychopharmacology 4 (4): 301–11. October 1989. doi:10.1097/00004850-198910000-00005. PMID 2691573. 
  3. "Clovoxamine kinetics in an early clinical trial". Clinical Pharmacology and Therapeutics 34 (2): 266–71. August 1983. doi:10.1038/clpt.1983.164. PMID 6872422. 
  4. "Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man". Journal of Neural Transmission 49 (1–2): 63–86. 1980. doi:10.1007/BF01249190. PMID 6777458. 
  5. "Biochemical effects in rats after acute and long-term treatment with clovoxamine". Archives Internationales de Pharmacodynamie et de Therapie 287 (2): 188–202. June 1987. PMID 2820327.